Articles
Puretech Health, the parent company of Follica, has recently issued a 2018 Annual Report to shareholders which contains news about its long-standing hair growth company. New Proprietary Compounds Among the important Follica news shared in the Puretech Annual Report is the mentioning of “next-generation proprietary compounds.” Yes, that compounds with an “s”, as in more…
Read More
Today, Cassiopea SpA has announced topline data from its fully completed phase 2 dose ranging trial for men with androgenic alopecia. The results of the trial were favorable. Phase 2 Trial for Clascoterone The trial which was completed by Cassiopea included 400 men and 4 different doses of clascoterone, also known as breezula, for the…
Read More
As we continue to await a meaningful treatment becoming available and/or progressing in the clinical trial setting, I have more photo results from RiverTown Therapeutics Inc. to share. This result is a continuation of a previous before and after of a 60 yr old male that has been shared on Follicle Thought from RiverTown. This…
Read MoreA new therapy targeting the PRL receptor to treat male and female pattern hair loss is being developed by a Chinese biopharmaceutical compay and Bayer AG. A press release was sent out April 7, 2019 by Hope Medicine Inc. detailing a newly signed licensing agreement with Bayer AG for the development of treatments for hair…
Read MoreI’ve received an update regarding the anticipated NGF-574H stem-cell derived cosmetic for hair growth which was originally developed by Medipost. According to Jay Lee, CEO of Celino Inc., Medipost has spun off its cosmetics business including the products NGF-574H and NGF-37 (for skin) into a new company called Celino Inc. Last year, it was reported…
Read More
A website for Rapunzel Biosciences, the hair growth biotech company founded by Angela Christiano, has finally surfaced online. It was several years ago when Dr. Christiano mentioned that she was forming a company called “Rapunzel” which was aimed at using stem cells to create hair follicle regeneration in the scalp. We did not hear anything…
Read MoreReplicel has shared a newsletter today, March 5, 2019, addressing several facets of the company’s progress and product development. The big question for many people lately has been an update on RCH-01/Shiseido, this topic is briefly addressed in the newsletter. Replicel states that “With the clinical study of RCH-01 now successfully completed in Japan, RepliCel…
Read More
I’ve been given a few samples of the male Trinov version and I thought it would be fun to do a little giveaway. Let’s start with one bottle. The winner selection will be random but please share a few words on how Follicle Thought has helped your life or something else you feel would make…
Read MoreHairClone of the UK will be winding up its crowdfunding campaign soon. Paul Kemp, CEO of HairClone, has released the 6th official HairClone newsletter today. The main theme of the newsletter is to allow people a last chance opportunity to own shares in HairClone via its crowdfunding campaign on CapitalCell. The rest of the newsletter…
Read More
On February 4, 2019 Follicum announced via press release they have completed a preclinical trial using a new cream-like topical formulation of their peptide FOL-005. In the trial, Follicum measured the effects of their topical FOL-005 against industry standard hair-growth drug minoxidil. The trial was done on mice and took about four weeks to complete.…
Read More